LivaNova Reports Second-Quarter 2023 Results
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2023...
Implants
Nalu Medical, Inc. Presents Important New Clinical Data for PNS and SCS at ASPN 2023
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”), a Carlsbad, California-based neurostimulation company that has miniaturized neurostimulation implants for the management of...
Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities
New manufacturing capacity allows Establishment Labs to provide over half the current world demand for breast implants and supports upcoming...
Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer
NEW YORK and LONDON, July 19, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing...
Monogram Orthopaedics Secures First Conditional Purchase Order to Initiate Pilot Program with Global Distributor
Moves from R&D to CommercializationAUSTIN, TX / ACCESSWIRE / July 18, 2023 / Monogram Orthopaedics Inc., (NASDAQ:MGRM) ("Monogram" or the...
CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition
BELLEVUE, Wash.--(BUSINESS WIRE)--#CurvaFix--CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of...
XinRong Medical places a large purchase order of PediGuard® devices and invests in SpineGuard to boost DSG® technology’s deployment in China
PARIS & BOULDER, Colo.--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)...
Synapse Dental Pain Eraser Receives 2023 Cellerant Best of Class Hygiene Award for Setting a New Standard of Patient Care in Dentistry
CRANSTON, R.I., July 12, 2023 (GLOBE NEWSWIRE) -- The Synapse Dental Pain Eraser – the world’s first pen-shaped, portable, electronic...
IMPLANET Reports Revenue of €4.3 Million in the First Half of 2023
Q2 2023 revenue of €2.1 million, stable compared with Q2 2022 Continuation of the sales momentum for the new Medical...
The Orthopaedic Implant Company Announces Commercial Launch of the Innovative Threaded Metacarpal Nail System
Revolutionizing Hand Fracture Care with a Best-in-Breed Approach to Metacarpal FixationRENO, NV / ACCESSWIRE / July 11, 2023 / The...
Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden’s Latest Executive Order Expanding Contraceptive Coverage
PRINCETON, NJ / ACCESSWIRE / July 11, 2023 / - In June, President Biden issued an Executive Order on Strengthening...
Safe group group reports half-year revenues of €2.9m
Safe group group reports half-year revenues of €2.9m Second-quarter revenue of €1.4M in Q2 2022, stable compared with Q1...
Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study
Carlsbad, Calif, June 28, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a...
OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System
WARSAW, Ind., June 27, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
Femasys Announces FDA Approval of its IDE for the Pivotal Clinical Trial of FemBloc Permanent Birth Control, a Non-Surgical Alternative for Women
- Pivotal clinical trial to begin in the third quarter of 2023 - ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) --...
Sientra Announces Appointment of Alexander W. Casdin to Board of Directors
IRVINE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company...
Lyra Therapeutics to Present at Jefferies Healthcare Conference
WATERTOWN, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage biotechnology company developing innovative therapies...
Mithra Appoints Experienced Life Sciences Executive Christian Homsy* as Chairman
Inge Beernaert appointed President of the Compensation and Nomination CommitteeJacques Galloy appointed President of the Audit CommitteeLiege, Belgium, 29 May...
Lyra Therapeutics Announces $50.0 Million Private Placement
WATERTOWN, Mass., May 26, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology...
Sight Sciences Two Year Multicenter Study Results Show Sustained Reductions in Both Intraocular Pressure (IOP) and Glaucoma Medication Use in Mild-Moderate Primary Open Angle Glaucoma Patients Treated with a Procedure Enabled with the OMNI® Surgical System Technology
Retrospective Clinical Data from Seven US Sites Published in Clinical Ophthalmology Sustained and clinically meaningful IOP reductions observed at 12...